Multi-Component Breath Alcohol Intervention
BAMTECH
Development and Initial Testing of a Multi-Component Breath Alcohol- Focused Intervention for Young Adults
2 other identifiers
interventional
24
1 country
1
Brief Summary
This is the first stage of a three-stage, NIH-funded study to develop and test initially a multi-modal intervention concerning blood/breath alcohol concentration for young adults. The multimodal intervention will be made up of brief telehealth counseling and psychoeducation and use of three mobile technologies to facilitate moderate drinking. In the first stage of the study, we will conduct formative research to obtain input from the study population, test initially the telehealth version of the brief counseling and psychoeducation and to develop a simple, "low tech" approach to coaching participants to use the three mobile technologies in typical drinking situations. Participation will last approximately one month.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2023
CompletedFirst Posted
Study publicly available on registry
November 9, 2023
CompletedStudy Start
First participant enrolled
November 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 29, 2024
CompletedMay 14, 2026
May 1, 2026
10 months
October 30, 2023
May 12, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Technology utilization
Percentage of reported drinking days on which one reports that moderate drinking technology use has occurred
Across the field testing period, 2 weeks
Acceptability
Score on acceptability subscale of Modified System Usability Scale
At the end of the field testing period, 2 weeks
Usability
Score on acceptability subscale of Modified System Usability Scale
At the end of the field testing period, 2 weeks
Secondary Outcomes (3)
Drinks per drinking day
Across the field testing period, 2 weeks
Estimated blood alcohol content
Across the field testing period, 2 weeks
Negative consquences
At the end of the field testing period, 2 weeks
Study Arms (1)
Moderate drinking technologies with "lower tech" facilitation
EXPERIMENTALBrief motivational-interviewing-based counseling followed by use of three moderate drinking technologies (breath alcohol device and app, blood alcohol content estimator app and self-texting procedure) with "lower tech" facilitation.
Interventions
Participants will be asked to use the three mobile technologies as they choose while drinking for a two-week period.
Brief 25/30-minute motivational interview and psychoeducation on blood/breath alcohol concentration that includes both personalized and standardized information.
Study staff will review instructions for technology use closely with participants and guide them in use of existing phone technologies as reminders for use of the three moderate drinking technologies during drinking situations.
Eligibility Criteria
You may qualify if:
- Be between the ages of 18-25
- Be able to read English and complete study evaluations
- At least occasional heavy episodic drinking (i.e., 4 or more drinks for women and 5 or more drinks for men) over the prior 30 days
- Frequent consumption of at least one alcoholic drink during a minimum of 12 days out of the prior 30 so that subjects will have multiple opportunities to use the moderate drinking technologies during the intervention period.
You may not qualify if:
- Severe substance use disorder
- Be psychotic or otherwise severely psychiatrically disabled
- Report a history of a medical condition that would contraindicate the consumption of alcohol (e.g., liver disease, cardiac abnormality, pancreatitis, diabetes, neurological problems, and gastrointestinal disorders)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
EDGE Lab
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert F Leeman, PhD.
Northeastern University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2023
First Posted
November 9, 2023
Study Start
November 9, 2023
Primary Completion
August 29, 2024
Study Completion
August 29, 2024
Last Updated
May 14, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Study materials are available at any time upon request. Datasets with identifiers removed will be available after publication of the main outcome paper from the study
- Access Criteria
- Any qualified investigator upon request
Study materials and datasets with identifiers removed will be shared with other investigators upon request